Abstract
To develop novel anti-breast cancer agents and discuss the structure-activity relationship of bis-isatin scaffolds. Breast cancer is the most common invasive cancer and the second leading cause of cancer death in women after lung cancer. Bis-isatin scaffolds possess potential anti-breast cancer activity, and some of them such as Indirubin could induce cancer cells apoptosis via multiply mechanisms. The primary objective of this study was to evaluate the potential of bis-isatin scaffolds with alkyl/ether linkers between the two isatin moieties against different human breast cancer cell lines including MCF-7, AU565, MDA-MB-231, MDA-MB-435 and MDA-MB-468 cells. The synthesized bis-isatin scaffolds with alkyl/ether linker between the two isatin moieties were evaluated for their in vitro activity against MCF-7, AU565, MDA-MB-231, MDA-MB-435, and MDA-MB-468 human breast cancer cell lines by MTT assay. All the synthesized compounds (IC50: 38.3-197.6 µM) possess considerable activity against MCF-7, AU565, MDA-MB-231, MDA-MB-435, and MDA-MB-468 human breast cancer cell lines, and the most potent compound 4e (IC50: 38.3-63.5 µM) was no inferior to Cisplatin (IC50: 20.1-38.6 μM) against the five tested human breast cancer cell lines. All ...Continue Reading
References
Oct 16, 2008·Anti-cancer Agents in Medicinal Chemistry·M K Hadden, B S J Blagg
Jul 24, 2012·European Journal of Medicinal Chemistry·Pardeep SinghVipan Kumar
Nov 6, 2012·European Journal of Medicinal Chemistry·Kewal KumarVipan Kumar
Aug 7, 2013·Hematology/oncology Clinics of North America·Michael J Hassett, Elena B Elkin
Nov 2, 2013·European Journal of Medicinal Chemistry·Chengyuan LiangJing Gao
Feb 18, 2016·Bioorganic & Medicinal Chemistry Letters·Nikolai M EvdokimovAlexander Kornienko
Mar 25, 2016·Journal of Medicinal Chemistry·Tony FröhlichSvetlana B Tsogoeva
Oct 4, 2017·CA: a Cancer Journal for Clinicians·Carol E DeSantisAhmedin Jemal
Feb 24, 2018·Current Topics in Medicinal Chemistry·Qing-Cheng RenFeng Zhao
Apr 10, 2018·Fitoterapia·Yan XuShijia Zhao
Oct 17, 2018·Drug Design, Development and Therapy·Lihong ChenJifen Hu
Jul 17, 2019·Current Pharmaceutical Design·Aida Raigon-PonferradaJosé Cruz-Mañas
Aug 7, 2019·Current Topics in Medicinal Chemistry·Leonel Montealegre-SánchezEliécer Jiménez-Charris
Dec 25, 2019·Seminars in Cancer Biology·Muhammad AfzalFiroz Anwar
Jan 22, 2020·Archiv der Pharmazie·Zhen DingCheng Zeng
Jan 28, 2020·Archiv der Pharmazie·Ya-Zhou ZhangZhi Xu